- Page 2 and 3: Pompe’s disease The mouse as mode
- Page 4 and 5: Pompe’s disease The mouse as mode
- Page 6: Contents Chapter 1 Introduction 11
- Page 12 and 13: Introduction Chapter 1 1.1 Lysosoma
- Page 14 and 15: Introduction Glycoproteins, such as
- Page 16 and 17: Table 1. Glycoprotein receptors inv
- Page 18 and 19: Introduction heart (63). Massive va
- Page 20 and 21: Introduction mutations have to be j
- Page 22 and 23: Introduction The 6 neo /6 neo and
- Page 24 and 25: Introduction Acid α-glucosidase pr
- Page 26 and 27: Introduction 16. Reitman, M.L. and
- Page 28 and 29: Introduction 79. Hers, H.G. and T.
- Page 30: Introduction 143. Martiniuk, F., et
- Page 34 and 35: Cardiac remodeling and contractile
- Page 36 and 37: Cardiac remodeling and contractile
- Page 38 and 39: Cardiac remodeling and contractile
- Page 40 and 41: Cardiac remodeling and contractile
- Page 42 and 43: Cardiac remodeling and contractile
- Page 44 and 45: Cardiac remodeling and contractile
- Page 46: Cardiac remodeling and contractile
- Page 50 and 51: ERT in infantile Pompe’s disease
- Page 52 and 53: ERT in infantile Pompe’s disease
- Page 54 and 55: ERT in infantile Pompe’s disease
- Page 56 and 57: A. B. ERT in infantile Pompe’s di
- Page 58 and 59: Fig. 4. Motor development. A. Patie
- Page 60 and 61:
ERT in infantile Pompe’s disease
- Page 62:
ERT in infantile Pompe’s disease
- Page 66 and 67:
Morphologigal changes in muscle tis
- Page 68 and 69:
Morphologigal changes in muscle tis
- Page 70 and 71:
Morphologigal changes in muscle tis
- Page 72 and 73:
Morphologigal changes in muscle tis
- Page 74 and 75:
Morphologigal changes in muscle tis
- Page 76:
Morphologigal changes in muscle tis
- Page 80 and 81:
Hearing loss in infantile Pompe’s
- Page 82 and 83:
Hearing loss in infantile Pompe’s
- Page 84 and 85:
Hearing loss in infantile Pompe’s
- Page 86 and 87:
A B C Fig. 4. Unstained sections of
- Page 88:
Hearing loss in infantile Pompe’s
- Page 92 and 93:
Enzyme replacement therapy and the
- Page 94 and 95:
Enzyme replacement therapy and the
- Page 96 and 97:
α-glucosidase activity nmol MU/mg/
- Page 98 and 99:
Liver Heart Enzyme replacement ther
- Page 100 and 101:
Enzyme replacement therapy and the
- Page 102 and 103:
Enzyme replacement therapy and the
- Page 104:
Enzyme replacement therapy and the
- Page 108 and 109:
Chapter 7 7 Discussion Animal model
- Page 110 and 111:
Discussion glycogen from the endoth
- Page 112 and 113:
Discussion Response to therapy Desp
- Page 114 and 115:
Discussion Notably, α-glucosidase
- Page 116 and 117:
Discussion 16. Linhart, A., et al.,
- Page 118 and 119:
Summary Pompe’s disease or glycog
- Page 120 and 121:
Samenvatting De ziekte van Pompe, o
- Page 122 and 123:
Curriculum vitae (Door R. Kamphoven
- Page 124 and 125:
List of abbreviations bAGLU acid α
- Page 126 and 127:
In memoriam Dr. Johannes Cassianus
- Page 128 and 129:
Hollen of stilstaan, het lijkt also